To leverage all available biomedical research resources including technical expertise, hardware, and research mentors for the long-term goal of enhanced productivity and competitiveness, Xavier's RCMI will strive to build and expand strong, productive collaborations and partnerships both intra-institutionally and inter-institutionally. We have identified and assessed resources available to Xavier's research community and will focus on the research resources in collaborating institutions and the research strengths of Xavier's RCMI program, as well as taking advantage of the RCMI Translational Research Network (RTRN) for enhancing collaborative research among RCMI institutions. We propose the three specific aims in building extensive collaborations and partnerships:
Aim 1. Expand and enhance intra-institutional collaborations and partnerships among Xavier researchers by offering state-of-the-art core facilities and technical expertise that support and promote interdisciplinary research activities;
Aim 2. Strengthen collaborations and partnerships with RCMI institutions by effectively utilizing RTRN resources and the eagle-i database;
and Aim 3. Strengthen collaborations with Xavier's strategic partners at the Louisiana Cancer Research Consortium and the Louisiana Biomedical Research Network and develop new collaborations with the Louisiana Clinical and Translational Sciences Center. Through effective collaborations, Xavier's RCMI program will benefit from additional professional development resources such as mentors, increase funding opportunities such as multi-PI grant applications, and enhance research capabilities and competitiveness by having access to state-of-the-art technologies and instrumentation.

National Institute of Health (NIH)
National Institute on Minority Health and Health Disparities (NIMHD)
Research Centers in Minority Institutions Award (G12)
Project #
Application #
Study Section
Special Emphasis Panel (ZMD1-MLS (01))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Xavier University of Louisiana
New Orleans
United States
Zip Code
Stratford Jr, Robert; Vu, Christopher; Sakon, Joshua et al. (2014) Pharmacokinetics in rats of a long-acting human parathyroid hormone-collagen binding domain peptide construct. J Pharm Sci 103:768-75
Pingali, Subramanya; Donahue, James P; Payton-Stewart, Florastina (2014) Weak C-H···X (X = O, N) hydrogen bonds in the crystal structure of dihydroberberine. Acta Crystallogr C Struct Chem 70:388-91
Zheng, Shilong; Zhong, Qiu; Mottamal, Madhusoodanan et al. (2014) Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents. J Med Chem 57:3369-81
Dougherty, Casey A; Furgal, Joseph C; van Dongen, Mallory A et al. (2014) Isolation and characterization of precise dye/dendrimer ratios. Chemistry 20:4638-45
Li, Xiao-Lin; Sluijter, Marjolein; Doorduijn, Elien M et al. (2014) Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase. PLoS One 9:e108192
Sridhar, Jayalakshmi; Sfondouris, Mary E; Bratton, Melyssa R et al. (2014) Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer. Bioorg Med Chem Lett 24:126-31
Zheng, Shilong; Zhong, Qiu; Xi, Yulan et al. (2014) Modification and biological evaluation of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion. J Med Chem 57:6653-67
Payton-Stewart, Florastina; Tilghman, Syreeta L; Williams, LaKeisha G et al. (2014) Benzimidazoles diminish ERE transcriptional activity and cell growth in breast cancer cells. Biochem Biophys Res Commun 450:1358-62
Samaan, Nawras; Zhong, Qiu; Fernandez, Jayjoel et al. (2014) Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents. Eur J Med Chem 75:123-31
Ledet, Grace; Pamujula, Sarala; Walker, Valencia et al. (2014) Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery. Drug Dev Ind Pharm 40:370-9

Showing the most recent 10 out of 33 publications